Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
| DUOPHARMA BIOTECH BERHAD |
Particulars of substantial Securities Holder
| Name | YAYASAN PELABURAN BUMIPUTRA |
| Address |
c/o Permodalan Nasional Berhad, Tingkat 4, Balai PNB, 201-A, Jalan Tun Razak,
Kuala Lumpur 50400 Wilayah Persekutuan Malaysia. |
| Company No. | 197801000107 (37113-P) |
| Nationality/Country of incorporation | Malaysia |
| Descriptions (Class) | Ordinary Shares |
Details of changes
| No | Date of change | No of securities |
Type of Transaction | Nature of Interest |
| 17 May 2022 | 5,612,760 |
Others | Direct Interest | |
| Name of registered holder | PERMODALAN NASIONAL BERHAD | |||
| Address of registered holder | Tingkat 4, Balai PNB, 201-A, Jalan Tun Razak, 50400 Kuala Lumpur. | |||
| Description of "Others" Type of Transaction | DRP | |||
| Circumstances by reason of which change has occurred | Permodalan Nasional Berhad elected to reinvest in 5,612,760 new shares pursuant to the Dividend Reinvestment Plan ("DRP"). |
| Nature of interest | Indirect Interest |
| Direct (units) | |
| Direct (%) | |
| Indirect/deemed interest (units) | 412,566,664 |
| Indirect/deemed interest (%) | 43.326 |
| Total no of securities after change | 412,566,664 |
| Date of notice | 17 May 2022 |
| Date notice received by Listed Issuer | 19 May 2022 |
| Remarks : |
Remarks :
Permodalan Nasional Berhad elected to reinvest their second interim dividend of 0.018 sen per ordinary share in Duopharma Biotech Berhad ("Duopharma") for the financial year ended 31 December 2021 in new Duopharma shares pursuant to the Dividend Reinvestment Plan ("DRP"). With the listing of the new Duopharma shares, the enlarged issued share capital of DBB is 952,239,690 shares.
Yayasan Pelaburan Bumiputra is deemed to have indirect interest through its shareholding of 100% less one share of Permodalan Nasional Berhad by virtue of Section 8(4) of the Companies Act, 2016. |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BERHAD |
| Stock Name | DPHARMA |
| Date Announced | 19 May 2022 |
| Category | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 |
| Reference Number | CS2-19052022-00005 |